Sean P. Carruthers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sean P. Carruthers has a total of 275 co-authors. Here are the top co-authors by number of shared publications:
- Susan Lee Rossell
Swinburne University of Technology
14 shared publications Susan L. Rossell
Swinburne University
9 shared publications- Tamsyn Elizabeth Van Rheenen
Melbourne Neuropsychiatry Centre, Department of Psychiatry, University of Melbourne and Melbourne Health, Melbourne, Australia
8 shared publications Philip J. Sumner
Centre for Mental Health, Swinburne University of Technology, Hawthorne, Victoria, Australia
6 shared publications- Christos Pantelis
The University of Melbourne
5 shared publications Erica Neill
Orygen, Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, Australia
5 shared publications
Latest Publications
- Open Access
Structural brain network organization and aggressive behavior in schizophrenia: a mega-analysis of 2260 patients and 3058 healthy controls from the ENIGMA-Schizophrenia Working Group
Background: Although most individuals with schizophrenia do not show aggressive behavior, rates are higher than in the general population. Identifying the neurobiological correlates of aggression may inform prevention. Methods: We included 2260 individuals with schizophrenia spectrum disorders and 3058 healthy controls (HC) from 26 sites in the ENIGMA-Schizophrenia Working Group. The former were classified as showing at least moderate aggression (SZ+A; N = 231) or not (SZ−A; N = 2029) based on symptom rating scales. Structural covariance networks were constructed from cortical and subcortical volumes. We examined global and nodal network topology, as well as density within six large-scale brain networks and between each network and the rest of the brain. Metrics were summarized as the area under the curve (AUC) across a prespecified range of densities ( K = 0.10–0.25, Δ K = 0.01). Group differences were assessed using pairwise permutation tests with Benjamini–Hochberg correction for multiple comparisons. Results: Global and nodal network topology did not differ significantly between SZ+A and HC. Network–rest density of the salience network (SN) was higher in SZ+A than in HC, although this difference did not survive multiple-comparison correction (ΔAUC = 0.018, p BH = .083). In exploratory subgroup analyses, higher SN network–rest density was observed only in SZ+A with high delusion severity (ΔAUC = 0.021, p = .007). By contrast, SZ−A demonstrated extensive alterations in global network topology compared with SZ+A and HC, alongside selective alterations in nodal topology and large-scale network density compared with HC. Results were broadly consistent across sensitivity analyses using alternative definitions of aggression and adjusting for current antipsychotic dose. Conclusions: SZ+A was characterized by fewer—not more—abnormalities in structural covariance network organization than SZ−A, which may reflect etiological heterogeneity. In SZ+A with high delusion severity, higher network–rest density of the SN may point to aberrant salience processing in aggressive behavior.
Open AccessStructural brain network organization and aggressive behavior in schizophrenia: a mega-analysis of 2260 patients and 3058 healthy controls from the ENIGMA-Schizophrenia Working Group
Background: Although most individuals with schizophrenia do not show aggressive behavior, rates are higher than in the general population. Identifying the neurobiological correlates of aggression may inform prevention. Methods: We included 2260 individuals with schizophrenia spectrum disorders and 3058 healthy controls (HC) from 26 sites in the ENIGMA-Schizophrenia Working Group. The former were classified as showing at least moderate aggression (SZ+A; N = 231) or not (SZ−A; N = 2029) based on symptom rating scales. Structural covariance networks were constructed from cortical and subcortical volumes. We examined global and nodal network topology, as well as density within six large-scale brain networks and between each network and the rest of the brain. Metrics were summarized as the area under the curve (AUC) across a prespecified range of densities ( K = 0.10–0.25, Δ K = 0.01). Group differences were assessed using pairwise permutation tests with Benjamini–Hochberg correction for multiple comparisons. Results: Global and nodal network topology did not differ significantly between SZ+A and HC. Network–rest density of the salience network (SN) was higher in SZ+A than in HC, although this difference did not survive multiple-comparison correction (ΔAUC = 0.018, p BH = .083). In exploratory subgroup analyses, higher SN network–rest density was observed only in SZ+A with high delusion severity (ΔAUC = 0.021, p = .007). By contrast, SZ−A demonstrated extensive alterations in global network topology compared with SZ+A and HC, alongside selective alterations in nodal topology and large-scale network density compared with HC. Results were broadly consistent across sensitivity analyses using alternative definitions of aggression and adjusting for current antipsychotic dose. Conclusions: SZ+A was characterized by fewer—not more—abnormalities in structural covariance network organization than SZ−A, which may reflect etiological heterogeneity. In SZ+A with high delusion severity, higher network–rest density of the SN may point to aberrant salience processing in aggressive behavior.
- Open Access
- 23 October 2026
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 56, e342
Distinct profiles of white matter diffusivity in obesity and bipolar disorders: An ENIGMA bipolar disorders study in 2166 individuals
Background: Bipolar disorders (BD) are associated with a wide range of brain white matter abnormalities, but results vary across studies. This heterogeneity likely relates to effects of additional clinical/diagnostic variables, including medications and obesity, on white matter in BD. In this mega-analysis, we studied the links between relevant clinical variables and four diffusivity measures. Methods: We obtained diffusion tensor imaging-derived fractional anisotropy (FA), mean, axial, and radial diffusivity (MD, AD, RD) values from 910 individuals with BD and 1256 healthy controls across 16 research sites in the ENIGMA-BD Working Group. We used principal component analysis to detect patterns of covariance across white matter tracts and studied associations between multivariate patterns of white matter alterations and demographic and clinical variables, including body mass index (BMI), medications, and diagnostic information, using mixed regression models. Results: Higher BMI was associated with lower PC1 FA and higher PC1 RD; BD was associated with higher PC1 MD, while treatment with antiepileptic medications was associated with lower PC1 FA, higher PC1 MD, and PC1 RD. Conclusions: We found FA and MD are weakly associated, providing complementary information, and there are unique associations between specific diffusivity measures and clinical predictors. Treatment with antiepileptics may inflate the statistical effects of BD on white matter. By using all diffusivity measures and accounting for additional clinical factors, we can gain new insights into brain correlates of severe mental illness.
- 23 October 2026
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 56, e342
Open AccessDistinct profiles of white matter diffusivity in obesity and bipolar disorders: An ENIGMA bipolar disorders study in 2166 individuals
Background: Bipolar disorders (BD) are associated with a wide range of brain white matter abnormalities, but results vary across studies. This heterogeneity likely relates to effects of additional clinical/diagnostic variables, including medications and obesity, on white matter in BD. In this mega-analysis, we studied the links between relevant clinical variables and four diffusivity measures. Methods: We obtained diffusion tensor imaging-derived fractional anisotropy (FA), mean, axial, and radial diffusivity (MD, AD, RD) values from 910 individuals with BD and 1256 healthy controls across 16 research sites in the ENIGMA-BD Working Group. We used principal component analysis to detect patterns of covariance across white matter tracts and studied associations between multivariate patterns of white matter alterations and demographic and clinical variables, including body mass index (BMI), medications, and diagnostic information, using mixed regression models. Results: Higher BMI was associated with lower PC1 FA and higher PC1 RD; BD was associated with higher PC1 MD, while treatment with antiepileptic medications was associated with lower PC1 FA, higher PC1 MD, and PC1 RD. Conclusions: We found FA and MD are weakly associated, providing complementary information, and there are unique associations between specific diffusivity measures and clinical predictors. Treatment with antiepileptics may inflate the statistical effects of BD on white matter. By using all diffusivity measures and accounting for additional clinical factors, we can gain new insights into brain correlates of severe mental illness.
- Open Access
- 5 March 2026
- Published by Center for Open Science in PsyArXiv
The Subjective Experience of Living with Binge Eating Disorder: A Systematic Review Protocol
Background: Binge Eating Disorder (BED) is the most prevalent specified eating disorder, however, understanding of how individuals experience the disorder remains limited. Qualitative research provides important insights into the lived experience of BED. Synthesising this evidence may enhance understanding of the disorder and inform clinical practice and future research. The objective of this review is to synthesise qualitative research examining how people with BED describe their experience of living with the disorder and its effects on their lives.Method: This systematic review will be conducted in accordance with the PRISMA 2020 guidelines. Eligible studies will include individuals with a current or past diagnosis of BED and report qualitative analyses of primary data collected directly from participants. Studies will be excluded if findings cannot be clearly attributed to participants with BED, if qualitative data derive from secondary sources, or if studies do not report on participant experiences of living with BED. Searches will be conducted in PubMed, Scopus, and PsycINFO from 2013 onwards. Methodological quality will be appraised using the CASP Qualitative Checklist. Qualitative findings will be synthesised using thematic synthesis. Discussion: This systematic review will synthesise the qualitative evidence on the lived experience of BED and identify key themes and gaps in the literature that may inform future research and clinical understanding.
- 5 March 2026
- Published by Center for Open Science in PsyArXiv
Open AccessThe Subjective Experience of Living with Binge Eating Disorder: A Systematic Review Protocol
Background: Binge Eating Disorder (BED) is the most prevalent specified eating disorder, however, understanding of how individuals experience the disorder remains limited. Qualitative research provides important insights into the lived experience of BED. Synthesising this evidence may enhance understanding of the disorder and inform clinical practice and future research. The objective of this review is to synthesise qualitative research examining how people with BED describe their experience of living with the disorder and its effects on their lives.Method: This systematic review will be conducted in accordance with the PRISMA 2020 guidelines. Eligible studies will include individuals with a current or past diagnosis of BED and report qualitative analyses of primary data collected directly from participants. Studies will be excluded if findings cannot be clearly attributed to participants with BED, if qualitative data derive from secondary sources, or if studies do not report on participant experiences of living with BED. Searches will be conducted in PubMed, Scopus, and PsycINFO from 2013 onwards. Methodological quality will be appraised using the CASP Qualitative Checklist. Qualitative findings will be synthesised using thematic synthesis. Discussion: This systematic review will synthesise the qualitative evidence on the lived experience of BED and identify key themes and gaps in the literature that may inform future research and clinical understanding.
- Open Access
- 20 January 2026
- Published by Elsevier in Journal of Affective Disorders
- Vol. 400, 121220
Insights into psilocybin use among people with bipolar disorder: A thematic analysis of Reddit posts
- 20 January 2026
- Published by Elsevier in Journal of Affective Disorders
- Vol. 400, 121220
Open AccessInsights into psilocybin use among people with bipolar disorder: A thematic analysis of Reddit posts
- Open Access
- 24 February 2025
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 59 (4) , 315-321
Advancing the quality and safety of behavioural interventions in mental health research: A how-to guide from the MAGNET Clinical Trial Network
This is the first in a series of Position Papers from the Mental Health Australia General Clinical Trials Network (MAGNET) intended to promote the standard of mental health research in Australia. This paper focuses on improving the quality and safety of non-pharmacological trials with a mental health focus, which for the purpose of this paper, are those testing ‘complex’ behavioural interventions (including lifestyle or psychotherapy interventions) with clinical populations. This is timely after last year’s update of the National Statement for Ethical Conduct in Human Research which is intended to provide extended guidance on assessing, mitigating and managing risk and the introduction of the Australian Commission on Safety & Quality in Healthcare’s National Clinical Trials Governance Framework. However, what the implementation of these research policies means for behavioural trials in mental health, given their many nuances, is only being realised. This paper outlines historical issues in the conduct of behavioural trials in mental health (lack of consensus on the concept of harm; lack of governance and inconsistent data collection and/or trial procedures around harms). Next, we detail the methods for developing recommendations to aid triallists’ monitoring and assessing safety during the conduct of behavioural mental health trials that evaluate lifestyle or psychotherapy interventions in clinical populations. Finally, we present a decision-making algorithm to support implementation. Ultimately, we intend to promote quality and safety of behavioural interventions in mental health, to better understand the risk/benefit profile of these treatments and to minimise unnecessary risk to participants and triallists.
- 24 February 2025
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 59 (4) , 315-321
Open AccessAdvancing the quality and safety of behavioural interventions in mental health research: A how-to guide from the MAGNET Clinical Trial Network
This is the first in a series of Position Papers from the Mental Health Australia General Clinical Trials Network (MAGNET) intended to promote the standard of mental health research in Australia. This paper focuses on improving the quality and safety of non-pharmacological trials with a mental health focus, which for the purpose of this paper, are those testing ‘complex’ behavioural interventions (including lifestyle or psychotherapy interventions) with clinical populations. This is timely after last year’s update of the National Statement for Ethical Conduct in Human Research which is intended to provide extended guidance on assessing, mitigating and managing risk and the introduction of the Australian Commission on Safety & Quality in Healthcare’s National Clinical Trials Governance Framework. However, what the implementation of these research policies means for behavioural trials in mental health, given their many nuances, is only being realised. This paper outlines historical issues in the conduct of behavioural trials in mental health (lack of consensus on the concept of harm; lack of governance and inconsistent data collection and/or trial procedures around harms). Next, we detail the methods for developing recommendations to aid triallists’ monitoring and assessing safety during the conduct of behavioural mental health trials that evaluate lifestyle or psychotherapy interventions in clinical populations. Finally, we present a decision-making algorithm to support implementation. Ultimately, we intend to promote quality and safety of behavioural interventions in mental health, to better understand the risk/benefit profile of these treatments and to minimise unnecessary risk to participants and triallists.
- Open Access
- 7 October 2024
- Published by Center for Open Science in PsyArXiv
Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol
IntroductionThere has been a surge in research into psilocybin-assisted psychotherapy over the past decade, with many studies indicating this may be an effective novel intervention for several mental health disorders. Researchers are increasingly incorporating qualitative analysis into their studies in recognition of the rich, contextual information this provides. This scoping review aims to identify the existing qualitative research on psilocybin-assisted psychotherapy for the treatment of mental health disorders, analyse trends in research questions and methods, and recognise opportunities for future qualitative research. Methods and AnalysisThe methodological guidelines set out in the JBI Manual for Evidence Synthesis (Aromataris et al., 2024) will be used to conduct the review. The review will include qualitative studies involving psilocybin-assisted psychotherapy, administered in a controlled research setting, for the treatment of any mental health disorder. Microdosing studies will be excluded. PubMed, Scopus, PsycNET, and reference lists of included studies will be searched. Two reviewers will screen papers for inclusion. Data will be extracted into a table and findings will be presented in a narrative form. Relevant qualitative research will be identified, trends in the qualitative research questions and methods will be analysed, and opportunities for future qualitative research will be discussed.Ethics and DisseminationEthics approval is not required. Findings will be submitted for publication in a peer-reviewed journal. Key Words or PhrasesAnxiety, depression, psilocybin, psychedelic, qualitative.
- 7 October 2024
- Published by Center for Open Science in PsyArXiv
Open AccessQualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol
IntroductionThere has been a surge in research into psilocybin-assisted psychotherapy over the past decade, with many studies indicating this may be an effective novel intervention for several mental health disorders. Researchers are increasingly incorporating qualitative analysis into their studies in recognition of the rich, contextual information this provides. This scoping review aims to identify the existing qualitative research on psilocybin-assisted psychotherapy for the treatment of mental health disorders, analyse trends in research questions and methods, and recognise opportunities for future qualitative research. Methods and AnalysisThe methodological guidelines set out in the JBI Manual for Evidence Synthesis (Aromataris et al., 2024) will be used to conduct the review. The review will include qualitative studies involving psilocybin-assisted psychotherapy, administered in a controlled research setting, for the treatment of any mental health disorder. Microdosing studies will be excluded. PubMed, Scopus, PsycNET, and reference lists of included studies will be searched. Two reviewers will screen papers for inclusion. Data will be extracted into a table and findings will be presented in a narrative form. Relevant qualitative research will be identified, trends in the qualitative research questions and methods will be analysed, and opportunities for future qualitative research will be discussed.Ethics and DisseminationEthics approval is not required. Findings will be submitted for publication in a peer-reviewed journal. Key Words or PhrasesAnxiety, depression, psilocybin, psychedelic, qualitative.
- Open Access
- 29 May 2024
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 58 (11) , 930-951
Glutamatergic neurotransmission in schizophrenia: A systematic review and quantitative synthesis of proton magnetic resonance spectroscopy studies across schizophrenia spectrum disorders
Objective: Studies using proton magnetic resonance spectroscopy reveal substantial inconsistencies in the levels of brain glutamate, glutamine and glutamate + glutamine across schizophrenia spectrum disorders. This systematic review employs qualitative and quantitative methods to analyse the patterns and relationships between glutamatergic metabolites, schizophrenia spectrum disorders and brain regions. Methods: A literature search was conducted using various databases with keywords including glutamate, glutamine, schizophrenia, psychosis and proton magnetic resonance spectroscopy. Inclusion criteria were limited to case-control studies that reported glutamatergic metabolite levels in adult patients with a schizophrenia spectrum disorder diagnosis – i.e. first-episode psychosis, schizophrenia, treatment-resistant schizophrenia and/or ultra-treatment-resistant schizophrenia – using proton magnetic resonance spectroscopy at 3 T or above. Pooled study data were synthesized and analysed. Results: A total of 92 studies met the inclusion criteria, including 2721 healthy controls and 2822 schizophrenia spectrum disorder participants. Glu levels were higher in the basal ganglia, frontal cortex and medial prefrontal of first-episode psychosis participants, contrasting overall lower levels in schizophrenia participants. For Gln, strong differences in metabolite levels were evident in the basal ganglia, dorsolateral prefrontal cortex and frontal cortex, with first-episode psychosis showing significantly higher levels in the basal ganglia. In glutamate + glutamine, higher metabolite levels were found across schizophrenia spectrum disorder groups, particularly in the basal ganglia and dorsolateral prefrontal cortex of treatment-resistant schizophrenia participants. Significant relationships were found between metabolite levels and medication status, clinical measures and methodological variables. Conclusion: The review highlights abnormal glutamatergic metabolite levels throughout schizophrenia spectrum disorders and in specific brain regions. The review underscores the importance of standardized future research assessing glutamatergic metabolites using proton magnetic resonance spectroscopy due to considerable literature heterogeneity.
- 29 May 2024
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 58 (11) , 930-951
Open AccessGlutamatergic neurotransmission in schizophrenia: A systematic review and quantitative synthesis of proton magnetic resonance spectroscopy studies across schizophrenia spectrum disorders
Objective: Studies using proton magnetic resonance spectroscopy reveal substantial inconsistencies in the levels of brain glutamate, glutamine and glutamate + glutamine across schizophrenia spectrum disorders. This systematic review employs qualitative and quantitative methods to analyse the patterns and relationships between glutamatergic metabolites, schizophrenia spectrum disorders and brain regions. Methods: A literature search was conducted using various databases with keywords including glutamate, glutamine, schizophrenia, psychosis and proton magnetic resonance spectroscopy. Inclusion criteria were limited to case-control studies that reported glutamatergic metabolite levels in adult patients with a schizophrenia spectrum disorder diagnosis – i.e. first-episode psychosis, schizophrenia, treatment-resistant schizophrenia and/or ultra-treatment-resistant schizophrenia – using proton magnetic resonance spectroscopy at 3 T or above. Pooled study data were synthesized and analysed. Results: A total of 92 studies met the inclusion criteria, including 2721 healthy controls and 2822 schizophrenia spectrum disorder participants. Glu levels were higher in the basal ganglia, frontal cortex and medial prefrontal of first-episode psychosis participants, contrasting overall lower levels in schizophrenia participants. For Gln, strong differences in metabolite levels were evident in the basal ganglia, dorsolateral prefrontal cortex and frontal cortex, with first-episode psychosis showing significantly higher levels in the basal ganglia. In glutamate + glutamine, higher metabolite levels were found across schizophrenia spectrum disorder groups, particularly in the basal ganglia and dorsolateral prefrontal cortex of treatment-resistant schizophrenia participants. Significant relationships were found between metabolite levels and medication status, clinical measures and methodological variables. Conclusion: The review highlights abnormal glutamatergic metabolite levels throughout schizophrenia spectrum disorders and in specific brain regions. The review underscores the importance of standardized future research assessing glutamatergic metabolites using proton magnetic resonance spectroscopy due to considerable literature heterogeneity.
- Open Access
- 22 November 2023
- Published by Springer Nature in Research Square
Flexible Goal-directed Cognition and Inner-Speech in Schizophrenia Spectrum Disorders: from clinical data to computational modeling, and backward.
Flexible goal-directed human cognition is supported by many forms of self-directed manipulation of representations. Among them, Inner-Speech (IS; covert self-directed speech) acts on second-order representations (e.g., goals/sub-goals), empowering attention and feedback processing. Interestingly, patients with Schizophrenia Spectrum Disorders (SSD) show impaired Executive Functions (EF; e.g., cognitive flexibility) and, probably, a related IS alteration. However, fragmentary evidence and no computational modeling prevent a clear assessment of these processes and focused therapeutic interventions. Here, we address these issues by exploiting a translational approach that integrates experimental clinical data, machine learning, and computational modeling. First, we administered the Wisconsin Cards Sorting Test (WCST; a neuropsychological test probing cognitive flexibility) to SSD patients and computed the behavioural data with a data-driven clustering algorithm. Second, we extracted the cluster neuropsychological profiles with our theory-based validated computational model of the WCST. Finally, we exploited our model to emulate an IS-based psychotherapeutic intervention for SSD subpopulations. We identified different SSD sub-populations and global trends (e.g., a descending feedback sensitivity); however, extremely different neuropsychological profiles emerged. In particular, `Relatively Intact' patients showed an unexpected profile (distraction/reasoning failures), quite divergent from the perseverative/rigid profile of the others. Importantly, the former showed no impact of Interfering-IS, while the others showed increased Interfering-IS strongly affecting their cognition. These differences highlight that SSD populations require a cluster-dependent individualisation of the intervention to achieve adequate cognitive performance. Overall, these results support a clear definition of neuropsychological profiles and the related Interfering-IS impact in SSD subpopulations, thus showing important implications for basic research (e.g., cognitive neuroscience) and clinical fields (clinical psychology and psychiatry).
- 22 November 2023
- Published by Springer Nature in Research Square
Open AccessFlexible Goal-directed Cognition and Inner-Speech in Schizophrenia Spectrum Disorders: from clinical data to computational modeling, and backward.
Flexible goal-directed human cognition is supported by many forms of self-directed manipulation of representations. Among them, Inner-Speech (IS; covert self-directed speech) acts on second-order representations (e.g., goals/sub-goals), empowering attention and feedback processing. Interestingly, patients with Schizophrenia Spectrum Disorders (SSD) show impaired Executive Functions (EF; e.g., cognitive flexibility) and, probably, a related IS alteration. However, fragmentary evidence and no computational modeling prevent a clear assessment of these processes and focused therapeutic interventions. Here, we address these issues by exploiting a translational approach that integrates experimental clinical data, machine learning, and computational modeling. First, we administered the Wisconsin Cards Sorting Test (WCST; a neuropsychological test probing cognitive flexibility) to SSD patients and computed the behavioural data with a data-driven clustering algorithm. Second, we extracted the cluster neuropsychological profiles with our theory-based validated computational model of the WCST. Finally, we exploited our model to emulate an IS-based psychotherapeutic intervention for SSD subpopulations. We identified different SSD sub-populations and global trends (e.g., a descending feedback sensitivity); however, extremely different neuropsychological profiles emerged. In particular, `Relatively Intact' patients showed an unexpected profile (distraction/reasoning failures), quite divergent from the perseverative/rigid profile of the others. Importantly, the former showed no impact of Interfering-IS, while the others showed increased Interfering-IS strongly affecting their cognition. These differences highlight that SSD populations require a cluster-dependent individualisation of the intervention to achieve adequate cognitive performance. Overall, these results support a clear definition of neuropsychological profiles and the related Interfering-IS impact in SSD subpopulations, thus showing important implications for basic research (e.g., cognitive neuroscience) and clinical fields (clinical psychology and psychiatry).
- 13 November 2023
- Published by Taylor & Francis
- p. 610-618
The Role of the Custody Nurse and Paramedic
The roles of nurse and paramedic within the police custody setting in the United Kingdon is reviewed with practical examples These rules generally apply to all police settings although there may be local variation. The nurse or paramedic working in custody is an autonomous practitioner working within the boundaries of their clinical competence, and so their roles may vary according to their clinical background and experience.
- 13 November 2023
- Published by Taylor & Francis
- p. 610-618
The Role of the Custody Nurse and Paramedic
The roles of nurse and paramedic within the police custody setting in the United Kingdon is reviewed with practical examples These rules generally apply to all police settings although there may be local variation. The nurse or paramedic working in custody is an autonomous practitioner working within the boundaries of their clinical competence, and so their roles may vary according to their clinical background and experience.
- Open Access
- 7 August 2023
- Published by Center for Open Science in PsyArXiv
Flexible Cognition and Inner-Speech in Schizophrenia Spectrum Disorder: applying Machine Learning and Modelling in Computational Psychiatry
Many forms of goal-directed manipulation of representations are at the basis of flexible human cognition (e.g., top-down attention). Among them, the inner speech (self-directed speech) acts on high-order representations (e.g., goals/rules). Patients with Schizophrenia Spectrum Disorders (SSD) show impaired cognitive flexibility and, probably, altered inner speech. Here we apply Machine Learning and computational modelling to investigate flexible cognition and inner speech in SSD patients. Our results suggest between-group differences (control vs. SSD) and within-group differences (SSD sub-groups) in cognitive flexibility and inner speech.
- 7 August 2023
- Published by Center for Open Science in PsyArXiv
Open AccessFlexible Cognition and Inner-Speech in Schizophrenia Spectrum Disorder: applying Machine Learning and Modelling in Computational Psychiatry
Many forms of goal-directed manipulation of representations are at the basis of flexible human cognition (e.g., top-down attention). Among them, the inner speech (self-directed speech) acts on high-order representations (e.g., goals/rules). Patients with Schizophrenia Spectrum Disorders (SSD) show impaired cognitive flexibility and, probably, altered inner speech. Here we apply Machine Learning and computational modelling to investigate flexible cognition and inner speech in SSD patients. Our results suggest between-group differences (control vs. SSD) and within-group differences (SSD sub-groups) in cognitive flexibility and inner speech.